Profound Medical (PROF)
(Delayed Data from NSDQ)
$4.34 USD
+0.21 (5.08%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $4.38 +0.04 (0.92%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Profound Medical has a market cap of $124.40M, which represents its share price of $4.13 multiplied by its outstanding shares number of 30.12M. As a small-cap company, PROF's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PROF 4.34 +0.21(5.08%)
Will PROF be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PROF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PROF
Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates (Revised)
Profound Medical (PROF) Reports Q2 Loss, Misses Revenue Estimates
PROF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates
Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Beats Revenue Estimates
Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates
Other News for PROF
Is PROF primed for upward momentum? Crossed Above 20 Day Moving Average shows up after surging 5.08%
PROF forms Pocket Pivot on September 19
The technical outlook for PROF is unchanged after it falls 1.78% on September 17
MACD Bullish Signal Line Cross appears for PROF after 1.22% move
Is PROF primed for downward momentum? 1,2,3 Retracement Bearish shows up after rising 1.24%